Virica develops viral enhancers that optimize the manufacturing of viral vectors and cell and gene therapies, allowing developers to deploy their products economically at scale. Virica’s Viral Sensitizer (VSE™) platform reduces production inefficiencies caused by innate anti-viral defenses in manufacturing cells. Purpose-formulated VSE combinations substantially increase manufacturing yields and reduce the cost of goods for a range of products, including vaccines, gene therapies, and cell therapies.
Visit Company Website
